1. Manuscripts should be send by this OJS system.
  2. Manuscripts should be submitted in Microsoft Word format.
  3. Manuscripts can be submitted in English or in Polish.
  4. The authors attach a signed declaration that the submitted paper is not and will not be submitted to any other journal. The submitted materials cannot be previously published elsewhere, either in whole or in part, and cannot be under review in other journals or publishers..
  5. The main document of each manuscript should be uploaded as a separate text file. Microsoft Word is preferred, although any editable text file is acceptable.
  6. Separate files for each figure are required. TIF, EPS, BMP, GIF, CDR, AI or JPG figure files are strongly preferred, at the standard resolutions (i.e. 300 dpi for photos, 1200 dpi for line art) and scaled to size. All files have to be named.
  7. Figures should not include names of patients, logos, symbolic landmarks or any other identification of their origin.



The main document of each manuscript should be written in the following order:

Title page

  • the full title of the article.
  • full name/s of author/s.
  • hospital and academic affiliations.
  • full name of head of research centre.
  • corresponding author contact information.


Formatting requirements

There are no strict formatting requirements but all manuscripts must contain the essential elements needed to convey your manuscript, for example

  • Introduction
  • Materials and Methods
  • Results

If your article includes any Videos and/or other Supplementary material, this should be included in your initial submission for peer review purposes.



Should not exceed 700 characters. Do not use abbreviations in the abstract. (including spaces).


Presenting the main idea of the paper. Should not exceed 186 characters (including spaces).

Key words

3 to 7 words for indexing purposes.

Digital photo of the main author

Main text

Original articles should be arranged with appropriate subheadings: Introduction; Objective; Materials and Methods; Results; Discussion; Conclusions. The author should avoid jargon, clichs and laboratory slang.


On first usage it is necessary to write the full form of a word or phrase in the text. All abbreviations should be explained in the article at first use.

The names of medicinal substances

Chemical names of medicinal substances must be used. Trade names are allowed only in the case of multicomponent formulations, which cannot be broken down into a single active substance, and for the names of device/therapeutic systems.


Should include all sources of financial support as well as potential conflict of interests for all authors.


Should be cited using numbers in square brackets on the line. The author should abbreviate titles of periodicals according to the style of Index Medicus, National Library of Medicine.

Tables and figures

If a figure or table is based on a different figure or table, please indicate the source. In the case of using a table or figure that the authors hold no copyright to, they must obtain the consent of their owner to use and select the source from which they come. Tables must not duplicate the main text. Tables should be attached as editable text, not as images. Tables should be numbered in accordance with their order in the text.


The funding sources should be listed as follows:

Financing: This work has been supported by: XXX [grant number].

If funding for research is not provided, please attach the following sentence: This research has not received any specific grant from public funding agencies, commercial or non-profit.


If manuscrpit involves human subjects and/or animals, and also if your manuscript includes case reports/case series, you need to provide the following:
Name of the ethical approval committee/Institutional Review Board they have obtained consent from along with approval number/ID.
Declaration confirming that the study was conducted in accordance with Helsinki Declaration.
Declaration that written informed consent was obtained from the participants of the study.
For case reports/case series involving minor subjects/children/infants, authors should confirm that the statements of written informed consent from legally authorized representatives/parents/guardians are available.
Since patients have a right to privacy, identifying information (including patients’ images, names, initials, or hospital numbers) should not be included in recordings, written descriptions, or photographs, unless the information is essential for scientific purposes. If so informed consent from the patient must be obtained for publication of these graphics in print and electronic form. If such consent has not been obtained, personal details of patients must be removed.



The Editorial Board of „OphthaTherapy. Therapies in Ophtalmology” takes under consideration for publication original articles with the understanding that neither the manuscript nor any part of its essential substance, tables or figures have been published previously in print form or electronically and are not under consideration by any other publication or electronic medium. This restriction does not apply to abstracts or press reports published in connection with scientific meetings. Copies of any closely related manuscripts should be submitted to the Editor along with the manuscript that is to be considered.

Each submission packet should include the statement signed by the first author that the work has not been published previously or submitted elsewhere for review and a copyright transfer.


Article size

Original Investigation (3000–6000 words including tables and figures)

Original investigations are considered full-length applied or basic research reports. They cover topics relevant to clinical and basic studies relevant to man in the following areas ophtalmology, surgery, physiology, and pharmacology. The work presented in the manuscript must be original; studies related to previous observations will be considered.


Rapid Communication (1000–3000 words including tables, figures)

Rapid Communication presenting succinctly the results of original scientific research. In the cover letter the author should justify the request for Rapid Communication. The review process is 10 days, authors are allowed one revision if accepted, and the final version of the paper appears in the next available issue of the journal.


Research Letter (up to 1000 words, including up to 10 references and 1 figure or table)

A Research Letter contains new data or a clinical observation, in a format that allows for rapid publication.


Review Article (up to 5000 words including tables, figures)

In-depth, comprehensive state of the art reviews on a ophthalmology topic are welcomed. The editor may invite the authors to prepare the review article.


Case Report (up to 2500 words including tables and figures)

Case Reports include case studies of 4 or fewer patients that describe a novel situation or add important insights into mechanisms, diagnosis or treatment of a disease.


Letter to the Editor (2000 words including tables, figures)

Opinion pieces concerning papers published in "OphthaTherapy" are particularly welcomed and all submissions are subject to editing. Letters commenting on past-published papers are sent to the corresponding author for a response. Letters are selected for their relevance and originality; not all letters submitted can be published.


Meeting Proceedings (up to 2500 words including tables, figures)

Reports of meeting proceedings are synopses of scientific meetings of interest to audience of the journal.


Hypothesis (up to 3000 words including tables and figures)

Novel insights into a significant questions or clinical issues are welcome, and will be peer reviewed. As the definition of „hypothesis” suggests, articles of this type should be, although they lack direct experimental evidence, closely tied to empirical data and lead to testable predictions.


Editorial Article (up to 5000 words including tables and figures)

Special Article is associated with a particular special event.



Submission to this journal proceeds totally online. Paper can be submitted as a PDF file or a Word document. It should contain high enough quality figures. Please note that individual figure files larger than 10 MB must be uploaded separately.



Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.

Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Indicate ORCiD number. Present the authors' affiliation addresses (where the actual work was done) below the names. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.

Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. This responsibility includes answering any future queries about Methodology and Materials. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.

Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.



Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.

Number the references in the list in the order in which they appear in the text. References should be given according to the Vancouver style, according to the following formula:

Reference to a journal article

Kowalski J, Nowak B, Nowakowski RBA. 1st Baltic Cardio-Oncology Meeting. OncoReview. 2010; 163: 51-9.

Reference to a journal publication with an article number

Kowalski J, Nowak B, Nowakowski RBA. 1st Baltic Cardio-Oncology Meeting. OncoReview. 2018; 19: e00205.

Reference to a book

Johnes Jr W, White EB. Cardiovascular complications in cancer. 4th ed. Medical Education, Warszawa 2010.

Reference to a chapter in an edited book

Mettam GR, Adams LB. Cardiotoxicity in breast cancer. In: Johnes Jr W, White EB. Cardiovascular complications in cancer. Medical Education, Warszawa 2010: 281-304.

Reference to a website

Cancer Research UK. Cancer statistics reports for the UK. (Access: 13.03.2013).

Reference to a dataset

Oguro M, Imahiro S, Saito S et al. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015.


Use of DOI is highly encouraged.

Note shortened form for last page number. e.g., 51-9. For more than 3 authors the first 3 should be listed followed by 'et al.'

Journal names should be abbreviated according to the List of Title Word Abbreviations.